(Press-News.org) New drugs which may have the potential to stop faulty brain cells dying and slow down the progression of Parkinson's, have been identified by scientists in a pioneering study which is the first of its kind.
Experts from the world leading Sheffield Institute for Translational Neuroscience (SITraN) conducted a large scale drugs trial in the lab using skin cells from people with this progressive neurological condition which affects one in every 500 people in the UK.
The researchers tested over 2,000 compounds to find out which ones could make faulty mitochondria work normally again. Mitochondria act as the power generators in all cells of our body, including the brain. Malfunctioning mitochondria are one of the main reasons why brain cells die in Parkinson's.
One of the promising medications identified though the research is a synthetic drug called ursodeoxycholic acid (UDCA). This licenced drug has been in clinical use for several decades to treat certain forms of liver disease which means that researchers will be able to immediately start a clinical trial to test its safety and tolerability in people with Parkinson's.
This will discover the optimum dose to ensure that enough of the drug reaches the part of the brain where Parkinson's develops. Based on this information, larger randomized controlled trials can be carried out to assess the potential of UDCA to treat Parkinson's.
The extensive drug screen, which took over five years to complete, was funded by leading research charity Parkinson's UK, and was carried out in collaboration with the University of Trondheim, Norway.
Dr Oliver Bandmann, Reader in Neurology at SITraN, said: "Parkinson's is so much more than just a movement disorder. It can also lead to depression and anxiety, and a host of distressing day to day problems like bladder and bowel dysfunction.
"The best treatments currently available only improve some of the symptoms, rather than tackle the reason why Parkinson's develops in the first place, so there is a desperate need for new drug treatments which could actually slow down the disease progression".
"We are hopeful that this group of drugs can one day make a real difference to the lives of people with Parkinson's".
The results of the ground breaking study are published in the leading Neuroscience journal BRAIN today.
Dr Kieran Breen, Director of Research and Innovation at Parkinson's UK commented "This is a really exciting time for Parkinson's research. For the first time, we are starting to identify drugs that will treat the Parkinson's – possibly slow down or halt its progression – rather than just the symptoms.
"This will bring us closer to our ultimate goal of a cure for Parkinson's. We look forward to working closely with Dr Bandmann to develop this treatment".
###
Notes for Editors
Parkinson's UK
Parkinson's UK is the UK's leading charity supporting those with the condition. Its mission is to find a cure and improve life for everyone affected by Parkinson's through cutting edge research, information, support and campaigning.
For advice, information and support, visit http://www.parkinsons.org.uk or call the free, confidential helpline on 0808 800 0303.
SITraN
For more information about the Sheffield Institute for Translational Neuroscience visit SITraN
The University of Sheffield
With nearly 25,000 of the brightest students from 117 countries coming to learn alongside 1,209 of the world's best academics, it is clear why the University of Sheffield is one of the UK's leading universities. Staff and students at Sheffield are committed to helping discover and understand the causes of things - and propose solutions that have the power to transform the world we live in.
A member of the Russell Group, the University of Sheffield has a reputation for world-class teaching and research excellence across a wide range of disciplines. The University of Sheffield has been named University of the Year in the Times Higher Education Awards 2011 for its exceptional performance in research, teaching, access and business performance. In addition, the University has won four Queen's Anniversary Prizes (1998, 2000, 2002, 2007), recognising the outstanding contribution by universities and colleges to the United Kingdom's intellectual, economic, cultural and social life.
One of the markers of a leading university is the quality of its alumni and Sheffield boasts five Nobel Prize winners among former staff and students. Its alumni have gone on to hold positions of great responsibility and influence all over the world, making significant contributions in their chosen fields.
Research partners and clients include Boeing, Rolls-Royce, Unilever, Boots, AstraZeneca, GSK, Siemens, Yorkshire Water and many more household names, as well as UK and overseas government agencies and charitable foundations.
The University has well-established partnerships with a number of universities and major corporations, both in the UK and abroad. The White Rose University Consortium (White Rose) a strategic partnership between 3 of the UK's leading research universities of Leeds, Sheffield and York. Since its creation in 1997 White Rose has secured more than £100M into the Universities.
For further information, please visit http://www.sheffield.ac.uk
For further information please contact: Amy Pullan, Media Relations Officer, on 0114 222 9859 or email a.l.pullan@sheffield.ac.uk
To read other news releases about the University of Sheffield, visit: http://www.shef.ac.uk/news
Ground breaking research identifies promising drugs for treating Parkinson's
2013-09-03
ELSE PRESS RELEASES FROM THIS DATE:
Nursing students lack effective role models for infection prevention: Study
2013-09-03
Washington, DC, September 3, 2013 – 100 percent of student nurses surveyed observed lapses in infection prevention and control practices during their clinical placements, according to a British study published in the September issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Infection prevention and control (IPC) education is a fundamental component of the nursing curriculum, but little is understood about nursing students' experience of IPC in the clinical setting ...
Can you predict complications with back surgery? Preoperative factors increase risk
2013-09-03
Philadelphia, Pa. (September 1, 2013) - For older adults undergoing surgery for spinal stenosis, some simple indicators of poor preoperative health predict a high risk of major medical complications, reports a study in the September 1 issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
In combination, these risk factors may help in identifying patients at increased risk of heart attack and other serious events after spinal stenosis surgery, according to the report by Dr Richard A. Deyo and colleagues of Oregon ...
Cleveland Clinic research finds no benefit over placebo in ASSURE trial
2013-09-03
Monday, Sept. 3, 2013, Cleveland: Patients with coronary artery disease and low levels of "good cholesterol – or high-density lipoprotein (HDL) – who were treated with a drug designed to increase HDL levels and reduce coronary plaque build-up, experienced no better results than those treated with placebo, according to research conducted by the Cleveland Clinic Coordinating Center for Clinical Research (C5Research).
The drug, RVX-208, induces the production of apolipoprotein A1 (apoA1), a major protein in HDL. Prior research has shown that higher levels of HDL are associated ...
An easier way to control genes
2013-09-03
CAMBRIDGE, MA -- MIT researchers have shown that they can turn genes on or off inside yeast and human cells by controlling when DNA is copied into messenger RNA — an advance that could allow scientists to better understand the function of those genes.
The technique could also make it easier to engineer cells that can monitor their environment, produce a drug or detect disease, says Timothy Lu, an assistant professor of electrical engineering and computer science and biological engineering and the senior author of a paper describing the new approach in the journal ACS ...
Young people at higher risk for stroke
2013-09-03
MAYWOOD, Il. -- Fifteen percent of the most common type of strokes occur in adolescents and young adults, and more young people are showing risk factors for such strokes, according to a report in the journal Neurology.
Neurologist Jose Biller of Loyola University Medical Center is a co-author of the report, a consensus statement developed by the American Academy of Neurology.
Between 532,000 and 852,000 persons ages 18 to 44 in the United States have had a stroke. U.S. hospital discharges for stroke among persons ages 15 to 44 increased 23-to-53 percent between 1995-1996 ...
Medicaid pays for nearly half of all births in the United States
2013-09-03
WASHINGTON, DC -- Medicaid paid for nearly half of the 3.8 million births in the United States in 2010 -- an amount that has been rising over time, according to a report out today. The study, published in the September 2013 issue of the peer-reviewed journal Women's Health Issues, offers the most comprehensive information to date on Medicaid financing of births in each of the 50 states and nationally.
The new data will help researchers gauge the impact of health reform on maternal and child health, the authors say. Under the Affordable Care Act (ACA), some states are ...
Body weight influences both the physical and mental quality of life
2013-09-03
Scientists from the Institute of Health Economics and Health Care Management (IGM) and from the Institute of Epidemiology II (EPI II) discovered that weight gain leads to deterioration in physical health. Female study participants, however, experienced improved mental quality of life as their weight increased, a result that was observed even in women who were already overweight when the study began. For this study, Professor Dr Rolf Holle, Michael Laxy and their team evaluated data from the population-based longitudinal KORA study on the association between body weight ...
Facebook use by organizations during crises helps public image, MU study finds
2013-09-03
COLUMBIA, Mo. -- Social networking sites have become incredibly popular in recent years, with Facebook now ranking as the third most popular website in the U.S. With so many people spending so much time on Facebook, public relations professionals are using the site more and more to communicate to the public. Now, researchers at the University of Missouri School of Journalism have found that posting public relations information on Facebook during a time of crisis can improve the overall image of the organization that is experiencing the crisis.
Seoyeon Hong, a doctoral ...
Blind mole-rats are resistant to chemically induced cancers
2013-09-03
CHAMPAIGN, Ill. — Like naked mole-rats (Heterocephalus gaber), blind mole-rats (of the genus Spalax) live underground in low-oxygen environments, are long-lived and resistant to cancer. A new study demonstrates just how cancer-resistant Spalax are, and suggests that the adaptations that help these rodents survive in low-oxygen environments also play a role in their longevity and cancer resistance.
The findings are reported in the journal Biomed Central: Biology.
"We've shown that, compared to mice and rats, blind mole-rats are highly resistant to carcinogens," said ...
Cleveland Clinic research finds blood pressure drug tends to slow coronary disease
2013-09-03
Tuesday, Sept. 3, 2013, Cleveland: Patients with clogged and hardened arteries who already have their blood pressure under control may benefit from an additional blood pressure-lowering medication, according to research from the Cleveland Clinic Coordinating Center for Clinical Research (C5Research).
The researchers found that the renin-inhibitor aliskiren tended to slow coronary disease progression and reduced the risk of death, stroke and heart attack in these patients by about 50 percent, compared to placebo, suggesting that patients with prehypertension may benefit ...